The Latest Breaking News from Abbott

U.S. Food and Drug Administration officials are investigating the death of another infant who was given formula made by Abbott Laboratories.

The medical device maker will keep its headquarters in the northern suburbs but says a downtown location works for employees who want to avoid a long commute.

Barely two weeks after production restarted at a Michigan plant that supplies baby formula, flooding in the area has shut down the work as supply continues to dry up nationwide.

Severe weather has forced Abbott Nutrition to pause production at a Michigan baby formula factory that had just restarted

Just a few weeks after reopening its baby formula Sturgis, Michigan plant, Abbott Laboratories (NYSE:ABT) said it paused EleCare specialty baby formula production after recent thunderstorms flooded part of the facility. The company has informed the FDA and will conduct comprehensive testing with an independent third party to ensure the plant is safe to…

The beleagured Sturgis plant only resumed production less than 2 weeks ago.

U.S. regulators have historically inspected baby formula plants at least once a year, but they did not inspect any of the three biggest manufacturers in 2020

Despite US efforts to increase supply, there are reports of babies being rushed to hospitals and a growing black market for formula

The company that runs the largest baby formula factory in the US has reopened its plant, but consumers may be waiting months before supply levels return to normal.